Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -115,554 | -92,441 | -69,021 | -35,731 | -135,893 |
| Depreciation Amortization | -2,506 | -1,595 | -864 | 94 | -1,901 |
| Accounts receivable | -30,139 | -12,538 | -12,908 | -13,264 | -16,621 |
| Accounts payable and accrued liabilities | 2,544 | N/A | N/A | N/A | 4,537 |
| Other Working Capital | 3,844 | 9,571 | 1,663 | -8,589 | 306 |
| Other Operating Activity | 58,784 | 36,158 | 28,937 | 19,701 | 32,079 |
| Operating Cash Flow | $-83,027 | $-60,845 | $-52,193 | $-37,789 | $-117,493 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,567 | -1,495 | -1,213 | -174 | -1,502 |
| Purchase Of Investment | -265,628 | -175,661 | -154,576 | -104,550 | -28,664 |
| Sale Of Investment | 73,000 | 37,535 | 13,040 | 2,500 | 174,770 |
| Purchase Sale Intangibles | -5,000 | N/A | N/A | N/A | -4,000 |
| Other Investing Activity | -5,000 | 0 | 0 | 0 | -4,000 |
| Investing Cash Flow | $-199,195 | $-139,621 | $-142,749 | $-102,224 | $140,604 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 75,000 | 75,000 | 75,000 | N/A | 10,000 |
| Debt Repayment | -31,877 | -31,877 | -31,877 | N/A | N/A |
| Common Stock Issued | 115,056 | 112,129 | 111,451 | 108,771 | 120,176 |
| Other Financing Activity | -3,523 | -3,523 | -3,484 | 0 | 0 |
| Financing Cash Flow | $154,656 | $151,729 | $151,090 | $108,771 | $130,176 |
| Beginning Cash Position | 224,947 | 224,947 | 224,947 | 224,947 | 71,660 |
| End Cash Position | 97,381 | 176,210 | 181,095 | 193,705 | 224,947 |
| Net Cash Flow | $-127,566 | $-48,737 | $-43,852 | $-31,242 | $153,287 |
| Free Cash Flow | |||||
| Operating Cash Flow | -83,027 | -60,845 | -52,193 | -37,789 | -117,493 |
| Capital Expenditure | -1,567 | -1,495 | -1,213 | -174 | -1,502 |
| Free Cash Flow | -84,594 | -62,340 | -53,406 | -37,963 | -118,995 |